Ananda Pharma (STU:1FX) Other Current Receivables: €0.00 Mil (As of Jul. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ananda Pharma Other Current Receivables?

Ananda Pharma STU:1FX Other Current Receivables is €0.00 Mil as of Jul. 2025. The stock has 5 warning signs investors should review.

Ananda Pharma's Other Current Receivables for the quarter that ended in Jul. 2025 was €0.00 Mil.

Ananda Pharma's annual Other Current Receivables declined from Jan. 2023 (€0.24 Mil) to Jan. 2024 (€0.09 Mil) but then increased from Jan. 2024 (€0.09 Mil) to Jan. 2025 (€0.19 Mil).

Ananda Pharma Other Current Receivables Related Terms

Ananda Pharma Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Ananda Pharma's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Other Current Receivables Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Other Current Receivables
Get a 7-Day Free Trial 0.00 0.10 0.24 0.09 0.19

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.09 0.00 0.19 0.00

Ananda Pharma Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.00 Mil mean?
Ananda Pharma (STU:1FX) has a Other Current Receivables of €0.00 Mil as of Jul. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ananda Pharma and its competitors.
Is Ananda Pharma's Other Current Receivables too high?
Ananda Pharma's current Other Current Receivables is €0.00 Mil.
How does Ananda Pharma's Other Current Receivables compare to ZTS and UTHR?
Ananda Pharma's Other Current Receivables of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ananda Pharma and its competitors. Ananda Pharma's current Other Current Receivables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (STU:1FX) has a current Other Current Receivables of €0.00 Mil. The current Other Current Receivables is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Ananda Pharma (STU:1FX), the current Other Current Receivables is €0.00 Mil as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ananda Pharma Business Description

Address 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).